Alkermes to sell South Roscommon plant for $92.5m - News
The Alkermes Chief Executive said the deal would offer employees at the Monksland facility “an exciting opportunity for growth"
Source: roscommonherald.ie
Page 29 - Alkermes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alkermes Today - Breaking & Trending Today
12 Best Growth Stocks to Buy According to Billionaire Ray Dalio's Bridgewater Associates
In this piece, we will take a look at the 12 best growth stocks to buy according to billionaire Ray Dalio’s Bridgewater Associates. If you want to see more stocks in this selection, then take a look at 5 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates. Since founding Bridgewater Associates […]
Source: yahoo.com
Alkermes (NASDAQ:ALKS) Issues FY 2023 Earnings Guidance
Alkermes (NASDAQ:ALKS – Get Free Report) issued an update on its FY 2023 earnings guidance on Monday morning. The company provided EPS guidance of 1.570-1.750 for the period, compared to the consensus EPS estimate of 1.590. The company issued revenue guidance of -. Alkermes Trading Up 0.9 % Shares of NASDAQ ALKS traded up $0.24 […]
Source: etfdailynews.com
Patient Advocacy and Community Engagement at Alkermes
NORTHAMPTON, MA / ACCESSWIRE / December 11, 2023 / AlkermesOriginally published in Alkermes September 2023 Corporate Responsibility ReportWe have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder - di...
Source: pharmiweb.com
Brokerages Set Alkermes plc (NASDAQ:ALKS) Price Target at $32.29
Alkermes plc (NASDAQ:ALKS – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price target among brokerages […]
Source: dailypolitical.com